What is Lonza in Slough?

Lonza operates a cGMP manufacturing facility in Slough, UK. Located close to Heathrow Airport in London in the Thames Valley technology corridor, the facility develops therapeutic grade monoclonal antibodies and recombinant proteins.

What does Lonza company do?

Lonza is a preferred global partner to the pharmaceutical, biotech and nutrition markets. We focus on enabling treatments that prevent illness and support healthier lifestyles. We optimize scientific innovation and manufacturing technology to enable our customers to serve their patients and consumers.

Is Lonza Big pharma?

Lonza Pharma, Biotech and Nutrition This segment is the world’s largest CDMO company, providing a wide range of products and services to the pharma, consumer healthcare and nutrition industries.

Is Lonza a pharmaceutical company?

Lonza Group is a Swiss multinational manufacturing company for the pharmaceutical, biotechnology and nutrition sectors, headquartered in Basel, with major facilities in Europe, North America and South Asia.

How many countries is Lonza?

35 countries
Founded in 1897 in the Swiss Alps, Lonza today operates in 120 sites and offices in more than 35 countries.

Who founded Lonza?

All this forms the background to the foundation of Lonza. In the mid-1890s, representatives of the Nuremburg-based company S. Schuckert & Co met with Swiss financiers, including the Basel banker Alfons Ehinger (Lonza’s first ever President).

How many employees does Lonza have in the UK?

The site originally belonged to Celltech Biologics and was acquired by Lonza in 1996. It currently operates with approximately 650 employees. A £16m expansion was announced on 29 March 2011 to further improve the operational capability of the facility.

What is the Slough Biopharm facility?

The facility is focused on the development and manufacture of therapeutic grade monoclonal antibodies and recombinant proteins. Our UK facility is in the industrial town of Slough, located 22 miles west of central London. Slough is a 226,000 ft2 (~21,000m2), multi-product cGMP manufacturing and development facility for Mammalian Biopharmaceuticals.

Is Lonza a FDA approved protein manufacturer?

Since then the facility has established itself as a successful protein manufacturer and passed inspections by all the major regulatory bodies — including MHRA, PMDA and FDA — the most recent of which was carried out in 2009. The site originally belonged to Celltech Biologics and was acquired by Lonza in 1996.

What is the quality management system at Slough?

Slough operates under the global quality management system which complies with internal policies as well as with national and international regulations. Since 2012, the site has hosted 22 GMP / PAI inspections for both monoclonal antibodies and recombinant proteins.